Pediatric Interventional Cardiology Market to Grow with a CAGR of 6.72% through 2030F
The rising incidence of
congenital heart diseases, the widespread adoption of minimally invasive
techniques, and technological innovations are expected to drive the Global
Pediatric Interventional Cardiology Market growth in the forecast period,
2026-2030F
According to TechSci
Research report, “Pediatric Interventional Cardiology Market – Global
Industry Size, Share, Trends, Competition Forecast & Opportunities,
2030”, the Global Pediatric Interventional Cardiology Market stood at USD
2.41 billion in 2024 and is anticipated to grow with a CAGR of 6.72% in the
forecast period, 2026-2030. This can be attributed to research and clinical
trials. Ongoing research and clinical trials are vital factors driving the
pediatric interventional cardiology market. These studies continually refine
existing procedures and explore new interventions, ensuring that the field
remains at the forefront of pediatric cardiac care. Patients and practitioners
benefit from evidence-based advancements in treatment options.
The research in gene
therapy and regenerative medicine holds promise for treating congenital heart
diseases at the genetic level. While still in the experimental phase, these
approaches may become more prominent in the future.
Browse over XX market
data Figures spread through XX Pages and an in-depth TOC on "Global Pediatric Interventional Cardiology Market”
The pediatric
interventional cardiology market was significantly impacted by the COVID-19
pandemic. Numerous global investigations have documented a decrease in
hospitalizations and cardiac procedures during this period. For instance, an
article published on PubMed in August 2022 highlighted the substantial impact
of the pandemic on the provision of pediatric cardiac care in India, resulting
in a two-thirds reduction in hospitalizations and cardiac surgeries. However,
with the pandemic now waning, hospitals have resumed their standard procedures.
Consequently, the studied market is anticipated to experience stable growth
throughout the forecast period of the study.
Market expansion is
expected to be driven by factors such as an increasing incidence of heart
disease and rapid technological advancements. The most prevalent congenital
condition is congenital heart defects (CHD). Ventricular septal defect (VSD) is the most common
heart defect in newborns. Consequently, the rising prevalence of CHD is
projected to drive the adoption of pediatric interventional cardiology devices.
The introduction of new
products and strategic initiatives by major market players is positively
influencing market growth. For instance, in July 2021, Abbott launched an
occluder, a self-expanding wire mesh device that can be inserted through a
small incision in the leg and navigated through vessels to the heart. Here, it
is positioned to seal heart openings, particularly to treat patent ductus
arteriosus (PDA). Remarkably, this device can be implanted in even the smallest
infants, weighing as little as 700 grams, using a minimally invasive procedure.
In summary, factors like
the increasing prevalence of heart disease and innovations from leading market
players are expected to drive market growth. However, stringent regulatory
policies and the costliness of treatments and therapies may pose challenges to
the expansion of the pediatric interventional cardiology market.
The Global Pediatric
Interventional Cardiology Market is segmented into device type, procedure,
regional distribution, and company.
Based on its device
type, Transcatheter Heart Valves are the fastest-growing category in the global
Pediatric Interventional Cardiology Market. This rapid growth is driven by
advancements in minimally invasive valve replacement technologies, which offer
safer alternatives to open-heart surgeries, especially in children with
congenital heart defects. The increasing prevalence of pediatric valve
disorders, such as aortic or pulmonary valve abnormalities, has further fueled
demand for these devices.
The growing success of
transcatheter aortic valve replacement (TAVR) in adults has led to expanded
research and adaptation of these technologies for pediatric use. Improved
device miniaturization and growing clinical evidence supporting their efficacy
in children contribute to their rising adoption. Hospitals and cardiology
centers are increasingly equipped with advanced imaging and catheterization
labs, enabling more precise and less invasive interventions. These factors
collectively make Transcatheter Heart Valves the most dynamic and rapidly
expanding segment in pediatric interventional cardiology worldwide.
Based on procedure, Among
the listed procedures, Catheter-Based Valve Implantation is the fastest-growing
segment in the global Pediatric Interventional Cardiology Market. This growth
is driven by its minimally invasive nature, offering significant advantages
over traditional open-heart surgeries, especially for pediatric patients. The
procedure involves implanting or replacing heart valves using catheters,
reducing surgical risks, shortening hospital stays, and minimizing recovery
times. Such benefits are particularly crucial for children, who are more
vulnerable to the complications associated with invasive surgeries.
Advancements in medical
technology have enhanced the precision and safety of catheter-based valve
implantation. The development of pediatric-specific devices and imaging
techniques has made the procedure more accessible and effective. The increasing
prevalence of congenital heart diseases requiring valve interventions has
heightened the demand for this less invasive option. Healthcare providers and
parents are increasingly opting for catheter-based solutions due to their
efficacy and reduced trauma to young patients. As a result, this segment is
experiencing substantial revenue growth and is poised to continue its upward
trajectory in the coming years.
.
Major companies
operating in Global Pediatric Interventional Cardiology Market are:
·
Abbott
Laboratories Inc
·
Biotronik
Inc
·
Boston
Scientific Corporation
·
Canon
Medical Systems Corp
·
Cardinal
Health Inc
·
Cordis
Corp
·
Edwards
Lifesciences LLC
·
GE
Healthcare Inc
·
Medtronic
Inc
·
Siemens
Healthineers AG
Download Free Sample Report
Customers can also
request for 10% free customization on this report.
“The Global Pediatric
Interventional Cardiology Market is poised for significant advancements in the
coming years, driven by the emerging trends. As technology continues to evolve
and our understanding of pediatric cardiac care deepens, children with heart
conditions stand to benefit from more precise, less invasive, and personalized
interventions. The collective efforts of healthcare providers, researchers, and
innovators worldwide are shaping a future where pediatric cardiac care is more
effective and patient-centric than ever before” said Mr. Karan Chechi, Research
Director with TechSci Research, a research-based management consulting firm.
“Pediatric Interventional Cardiology
Market, By Device Type (Closure Devices, Transcatheter Heart Valves,
Atherectomy Devices, Catheters, Balloons, Stents, Others), By Procedure
(Catheter-Based Valve Implantation, Congenital Heart Defect Correction,
Angioplasty, Coronary Thrombectomy, Others), By Region, By Competition
Forecast & Opportunities, 2020-2030F”, has evaluated the
future growth potential of Global Pediatric Interventional Cardiology Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Pediatric Interventional Cardiology
Market.
Contact
Mr. Ken
Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel:
+1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com